Digital Healthcare announces the appointment of Marc Winchester as president, North America, with immediate effect
Headquartered in Cambridge, UK, Digital Healthcare claims a reputation for providing user friendly software that combines high quality digital imaging systems with fully-automated data programmes which handle millions of patient records.
NHS Trusts are using the company's flagship product, OptoMize iP, to monitor the condition of hundreds of thousands of diabetes patients in large scale community eye screening programmes that are currently underway across the UK, as government screening targets require 100% of the diabetic population to have had access to a digital scan of their eyes by 2007.
In the USA, over 100 private practices, hospitals and universities use DH's software to screen patients for diseases such as glaucoma, retinopathy, cataracts and macular degeneration, as well as for longitudinal studies that measure the impact of new healthcare treatments.
Winchester joins DH as president and board director, assuming full operational and management responsibility to grow the business in North America, particularly in the key areas of messaging and high capacity imaging in chronic disease, clinical ophthalmology and clinical trials.
Winchester previously enjoyed a successful 22 year career with Misys Healthcare Systems, one of the top five healthcare IT companies in North America where he held a variety of senior positions, including senior vice president of sales and marketing for the ambulatory business unit, and was most recently in charge of market development for the healthcare division.
He was a key contributor to Misys's phenomenal growth with an impressive track record in sales, marketing and client relationship management.
Rob Stichbury, Digital Healthcare's managing director, said: "We have spent a great deal of time and effort searching for the right leader to take DH forward in the US market.
"Marc possesses the skills and experience that are essential to grow our business in North America and we are confident that he will make DH's US operations an outstanding success.
"We are delighted to have him join us at this exciting time".
Marc Winchester commented: "I am very happy to join DH and excited about the significant opportunities for DH in North America as the USA increasingly moves towards a preventative healthcare system based on the accurate diagnosis and early treatment of eye diseases".
